4//SEC Filing
MOULDER LEON O JR 4
Accession 0001104659-24-121081
CIK 0001953926other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:20 PM ET
Size
8.3 KB
Accession
0001104659-24-121081
Insider Transaction Report
Form 4
MOULDER LEON O JR
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2024-11-19$14.57/sh+2,500$36,425→ 171,155 total - Purchase
Common Stock
2024-11-18$15.00/sh+7,500$112,500→ 168,655 total
Holdings
- 1,672,039(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $14.81 to $15.32, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $14.50 to $14.62, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F3]Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC ("Tellus") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Zenas BioPharma, Inc.
CIK 0001953926
Entity typeother
Related Parties
1- filerCIK 0001228865
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 5:20 PM ET
- Size
- 8.3 KB